AIBRIEF
QC Ware's Promethium platform ran a public quantum chemistry calculation on IBM's 156 qubit Heron chip, on an enzyme whose iron active site breaks standard chemistry approximations.
An enzyme that helps bacteria turn nitrate into nitric oxide has electrons near its iron center so tangled that ordinary chemistry approximations miss what's actually happening. On Thursday, QC Ware, a Palo Alto drug-discovery software company, handed that small subproblem to a quantum chip while the rest of the molecule ran on a GPU.
The target was nitric oxide reductase, a metalloenzyme — a protein built around a metal ion — whose iron-containing active site is a textbook failure case for Density Functional Theory (DFT), the workhorse method chemists use to approximate electron behavior. The electrons near that iron are "strongly correlated": they influence each other so strongly that DFT produces what QC Ware calls "qualitatively wrong answers" on these systems.
The split: Promethium, QC Ware's GPU-accelerated chemistry platform, handled the bulk; IBM's 156-qubit Heron superconducting processor ran quantum measurements on the active-site subproblem. The quantity computed was the enzyme's electrostatic interaction energy.
QC Ware calls this the first publicly documented run of a commercial chemistry platform on live quantum hardware — and is careful to call it a demonstration. The hybrid workflow "is not currently a fully integrated Promethium product capability," and no peer-reviewed benchmark against classical methods is offered. What the run establishes is narrower and more useful: production chemistry software can now talk to a production quantum chip, with a clear division of labor for the hard part.